BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 32003552)

  • 1. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [
    Liang X; Yang C; Su M; Zou L
    Curr Med Res Opin; 2024 May; 40(5):803-811. PubMed ID: 38626218
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Bashank N; Sharef S; Mohran TZ; Khalil M
    EJNMMI Rep; 2024 Apr; 8(1):8. PubMed ID: 38748324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV+ Cells (KROG 18-09).
    Lee TH; Kim HJ; Lee JH; Lee J; Kim JH; Oh D; Eom KY
    Cancer Res Treat; 2024 Apr; 56(2):688-696. PubMed ID: 38097921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma.
    Alderuccio JP; Reis IM; Koff JL; Larson MC; Chihara D; Zhao W; Haddadi S; Habermann TM; Martin P; Chapman JR; Strouse C; Kahl BS; Cohen JB; Friedberg JW; Cerhan JR; Flowers CR; Lossos IS
    Blood; 2023 Apr; 141(15):1888-1893. PubMed ID: 36735908
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis.
    Martin-Moro F; Lopez-Jimenez J; Garcia-Marco JA; Garcia-Vela JA
    Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis.
    Zhang KD; Jost E; Panse J; Herwartz R; Lindemann-Docter K; Jonigk D; Kricheldorf K; Köchel A; Sauerbrunn N; Brümmendorf TH; Koschmieder S; Isfort S
    Ann Hematol; 2024 Apr; 103(4):1149-1158. PubMed ID: 38336973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials.
    Van Heertum RL; Scarimbolo R; Wolodzko JG; Klencke B; Messmann R; Tunc F; Sokol L; Agarwal R; Strafaci JA; O'Neal M
    Drug Des Devel Ther; 2017; 11():1719-1728. PubMed ID: 28670108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare involvement in skin cancer: Merkel cell carcinoma with bone marrow infiltration in a kidney transplant recipient.
    Durmus O; Gokoz O; Saglam EA; Ergun EL; Gulseren D
    Clin Med (Lond); 2023 May; 23(3):275-277. PubMed ID: 37236797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma.
    De Re V; Lopci E; Brisotto G; Elia C; Mussolin L; Mascarin M; d'Amore ESG; Aieop The Hodgkin's Lymphoma Research Network
    Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre
    Doma A; Zevnik K; Studen A; Prevodnik VK; Gasljevic G; Novakovic BJ
    Radiol Oncol; 2024 Mar; 58(1):15-22. PubMed ID: 38378029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
    Xiao-Xue W; Xinyue H; Lijun Z
    Med Clin (Barc); 2020 Jan; 154(2):61-65. PubMed ID: 31757394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
    Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Littooij AS; Nievelstein RA
    Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases.
    Büyükşimşek M; Kolsuz İ; Yetişir AE; Tohumcuoğlu M; Oğul A; Mirili C; Paydaş S; Güney İB
    Turk J Haematol; 2020 Nov; 37(4):220-225. PubMed ID: 32003552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of
    Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK
    Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.